Allarity Therapeutics (ALLR) Total Liabilities (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Total Liabilities came in at $28.0 million in Q1 2026, up 153.17% YoY from $11.1 million in Q1 2025, and up 232.18% on a QoQ basis from $8.4 million in Q4 2025.
Allarity Therapeutics (ALLR) Total Liabilities (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Total Liabilities data on file, last reported at $28.0 million in Q1 2026.
- Quarterly Total Liabilities rose 153.17% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.0 million (up 153.17% YoY) and the FY2025 annual result came in at $8.4 million, down 22.23% from the prior year.
- Total Liabilities grew to $28.0 million in Q1 2026, from $8.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $28.0 million in Q1 2026 to a low of $7.4 million in Q3 2024.
- A 5-year average of $13.4 million and a median of $13.0 million in 2023 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 4439.6% in 2022, down 58.98% in 2022.
- Tracing ALLR's Total Liabilities over 5 years: stood at $12.7 million in 2022, then grew by 15.48% to $14.6 million in 2023, then declined by 25.83% to $10.8 million in 2024, then fell by 22.23% to $8.4 million in 2025, then soared by 232.18% to $28.0 million in 2026.
- The last three Total Liabilities figures came in at $28.0 million (Q1 2026), $8.4 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 10.03 Bn |
| 10 | Allarity Therapeutics | 23.07 Mn | 23.07 Mn | - | 28.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.00 Mn |
| Dec 31, 2025 | 8.43 Mn |
| Sep 30, 2025 | 8.79 Mn |
| Jun 30, 2025 | 9.04 Mn |
| Mar 31, 2025 | 11.06 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Sep 30, 2024 | 7.41 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Mar 31, 2024 | 18.44 Mn |
| Dec 31, 2023 | 14.61 Mn |
| Sep 30, 2023 | 17.25 Mn |
| Jun 30, 2023 | 14.15 Mn |
| Mar 31, 2023 | 13.04 Mn |
| Dec 31, 2022 | 12.65 Mn |
| Sep 30, 2022 | 14.63 Mn |
| Jun 30, 2022 | 13.15 Mn |
| Mar 31, 2022 | 14.42 Mn |
| Dec 31, 2021 | 30.85 Mn |
| Sep 30, 2021 | 7.33 Mn |
| Jun 30, 2021 | -303,000.00 |